Cargando…

The cost‐effectiveness of prophylaxis strategies for individuals with advanced HIV starting treatment in Africa

INTRODUCTION: Many HIV‐positive individuals in Africa have advanced disease when initiating antiretroviral therapy (ART) so have high risks of opportunistic infections and death. The REALITY trial found that an enhanced‐prophylaxis package including fluconazole reduced mortality by 27% in individual...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walker, Simon M, Cox, Edward, Revill, Paul, Musiime, Victor, Bwakura‐Dangarembizi, Mutsa, Mallewa, Jane, Cheruiyot, Priscilla, Maitland, Kathryn, Ford, Nathan, Gibb, Diana M, Walker, A Sarah, Soares, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099175/ https://www.ncbi.nlm.nih.gov/pubmed/32219991 http://dx.doi.org/10.1002/jia2.25469

Ejemplares similares

Marginal structural models for repeated measures where intercept and slope are correlated: An application exploring the benefit of nutritional supplements on weight gain in HIV-infected children initiating antiretroviral therapy
por: Farmer, Ruth E., et al.
Publicado: (2020)

Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis
por: Prendergast, Andrew J., et al.
Publicado: (2016)

Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial
por: Siika, Abraham, et al.
Publicado: (2018)

Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial
por: Mallewa, Jane, et al.
Publicado: (2018)

Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIV
por: Ford, Deborah, et al.
Publicado: (2018)

Pharmacokinetics of Zidovudine Dosed Twice Daily According to World Health Organization Weight Bands in Ugandan HIV-infected Children
por: Fillekes, Quirine, et al.
Publicado: (2014)

Opportunities for improving the efficiency of paediatric HIV treatment programmes
por: Revill, Paul A., et al.
Publicado: (2015)

Pubertal development in HIV-infected African children on first-line antiretroviral therapy
por: Szubert, Alexander J., et al.
Publicado: (2015)

Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy
por: Crook, Angela M., et al.
Publicado: (2016)

“I don't feel shy because I will be among others who are just like me…”: The role of support groups for children perinatally infected with HIV in Zimbabwe
por: Mupambireyi, Zivai, et al.
Publicado: (2014)

Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial
por: Szubert, Alexander J., et al.
Publicado: (2017)

Pharmacokinetic Data of Dolutegravir in Second-line Treatment of Children With Human Immunodeficiency Virus: Results From the CHAPAS4 Trial
por: Bevers, Lisanne A H, et al.
Publicado: (2023)

Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy
por: Prendergast, Andrew J., et al.
Publicado: (2016)

Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial
por: Post, Frank A, et al.
Publicado: (2018)

Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort
por: Walker, AS, et al.
Publicado: (2010)

Prevalence of Lipodystrophy and Metabolic Abnormalities in HIV-infected African Children after 3 Years on First-line Antiretroviral Therapy
por: Bwakura-Dangarembizi, Mutsawashe, et al.
Publicado: (2015)

Ethical and legal constraints to children’s participation in research in Zimbabwe: experiences from the multicenter pediatric HIV ARROW trial
por: Bwakura-Dangarembizi, Mutsa, et al.
Publicado: (2012)

Impact of the COVID-19 pandemic on the provision and uptake of services for the prevention of mother-to-child transmission of HIV in Zimbabwe
por: Chappell, Elizabeth, et al.
Publicado: (2023)

Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial
por: Kityo, Cissy, et al.
Publicado: (2018)

Effect of handrubbing using locally-manufactured alcohol-based handrubs in paediatric wards in Harare, Zimbabwe
por: Gudza-Mugabe, Muchaneta, et al.
Publicado: (2017)

Carriage of antibiotic-resistant Enterobacteriaceae in hospitalised children in tertiary hospitals in Harare, Zimbabwe
por: Magwenzi, Marcelyn T., et al.
Publicado: (2017)

Brief Report: Cessation of Long-Term Cotrimoxazole Prophylaxis in HIV-Infected Children Does Not Alter the Carriage of Antimicrobial Resistance Genes
por: Francis, Freddy, et al.
Publicado: (2020)

Predicting Patterns of Long-Term CD4 Reconstitution in HIV-Infected Children Starting Antiretroviral Therapy in Sub-Saharan Africa: A Cohort-Based Modelling Study
por: Picat, Marie-Quitterie, et al.
Publicado: (2013)

Postdischarge interventions for children hospitalized with severe acute malnutrition: a systematic review and meta-analysis
por: Noble, Christie C A, et al.
Publicado: (2021)

Micronutrients and nutritional status among children living with HIV with and without severe acute malnutrition: IMPAACT P1092
por: Bwakura-Dangarembizi, Mutsa, et al.
Publicado: (2023)

First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial
por: Waalewijn, Hylke, et al.
Publicado: (2023)

Antiretroviral choice and severe disease predict poorer neuropsychological outcomes in HIV+ children from Africa
por: Fairlie, Lee, et al.
Publicado: (2022)

Haematological quality and age of donor blood issued for paediatric transfusion to four hospitals in sub‐Saharan Africa
por: Uyoga, Sophie, et al.
Publicado: (2019)

Inflammation: the driver of poor outcomes among children with severe acute malnutrition?
por: Sturgeon, Jonathan P, et al.
Publicado: (2023)

Population Pharmacokinetic Modeling of Dolutegravir to Optimize Pediatric Dosing in HIV-1-Infected Infants, Children, and Adolescents
por: Chandasana, Hardik, et al.
Publicado: (2023)

TAME trial: a multi-arm phase II randomised trial of four novel interventions for malnutrition enteropathy in Zambia and Zimbabwe - a study protocol
por: Kelly, Paul, et al.
Publicado: (2019)

Risk factors for postdischarge mortality following hospitalization for severe acute malnutrition in Zimbabwe and Zambia
por: Bwakura-Dangarembizi, Mutsa, et al.
Publicado: (2021)

Pharmacokinetics of lamivudine, abacavir and zidovudine administered twice daily as syrups versus scored tablets in HIV-1-infected Ugandan children
por: Gitta, PK, et al.
Publicado: (2010)

Getting Started with Netduino
por: Walker, Chris
Publicado: (2012)

Improved Adherence to Antiretroviral Therapy Observed Among HIV-Infected Children Whose Caregivers had Positive Beliefs in Medicine in Sub-Saharan Africa
por: Abongomera, G., et al.
Publicado: (2016)

Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial
por: Turkova, Anna, et al.
Publicado: (2022)

Fat and lean mass predict time to hospital readmission or mortality in children treated for complicated severe acute malnutrition in Zimbabwe and Zambia
por: Bwakura-Dangarembizi, Mutsa, et al.
Publicado: (2023)

Emerging and re‐emerging fungal threats in Africa
por: Dangarembizi, Rachael, et al.
Publicado: (2022)

Health Care Cost in Africa
por: Walker, ARP, et al.
Publicado: (2000)

Population level usage of health services, and HIV testing and care, prior to decentralization of antiretroviral therapy in Agago District in rural Northern Uganda
por: Abongomera, G., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ugr17ug55cli9o915fdqrii7n7